North America Intravenous Immunoglobulin Market Scope And Analysis

  • Report Code : TIPRE00030117
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 107
Buy Now

Analisi dell'ambito del mercato delle immunoglobuline endovenose in Nord America e concorrenti entro il 2023-2030

Buy Now

North America Intravenous Immunoglobulin Market Report North America Intravenous Immunoglobulin Market Size and Share North America Intravenous Immunoglobulin Market Scope and Analysis

North America Intravenous Immunoglobulin Market Report Scope

Report Attribute Details
Market size in 2022 US$ 5,042.91 Million
Market Size by 2030 US$ 8,747.81 Million
Global CAGR (2022 - 2030) 7.1%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Tipo
  • IgG
  • IgA
  • IgM
By Applicazione
  • Malattie da immunodeficienza
  • Polineuropatia demielinizzante infiammatoria cronica
  • Porpora trombocitopenica idiopatica
  • Neuropatia motoria multifocale
  • Ipogammaglobulinemia
  • Sindrome di Guillain-Barré
  • Deficit di anticorpi specifici
  • Miopatie infiammatorie
  • Miastenia grave
By Canale di distribuzione
  • farmacia ospedaliera
  • farmacia al dettaglio
By Utente finale
  • ospedali
  • cliniche specialistiche
Regions and Countries Covered Nord America
  • Stati Uniti
  • Canada
  • Messico
Market leaders and key company profiles
  • Takeda Pharmaceutical Co Ltd
  • Grifols SA
  • Pfizer Inc
  • ADMA Biologics, Inc
  • Bio Products Laboratory Ltd
  • Octapharma AG
  • Kedrion SpA
  • CSL Ltd
  • LFB Group